Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-flavivirus Properties of Lipid-Lowering Drugs
Carlos Noe Farfan‐Morales, Carlos Daniel Cordero‐Rivera, José Manuel Reyes-Ruíz, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Carolyn T. Bramante, Jared D. Huling, Christopher J. Tignanelli, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 7, pp. 599-610
Open Access | Times Cited: 207
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 89
Flavivirus nonstructural proteins and replication complexes as antiviral drug targets
Kaïn van den Elsen, Bing Liang Alvin Chew, Jun Sheng Ho, et al.
Current Opinion in Virology (2023) Vol. 59, pp. 101305-101305
Open Access | Times Cited: 24
Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access | Times Cited: 1
Mosquito-Borne Flaviviruses and Current Therapeutic Advances
Xijing Qian, Zhongtian Qi
Viruses (2022) Vol. 14, Iss. 6, pp. 1226-1226
Open Access | Times Cited: 33
Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds
Je-Wen Liou, Hemalatha Mani, Jui-Hung Yen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3897-3897
Open Access | Times Cited: 30
Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections
Juan Fidel Osuna‐Ramos, Carlos Noe Farfan‐Morales, Carlos Daniel Cordero‐Rivera, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1465-1465
Open Access | Times Cited: 21
Astrocytes derived from neural progenitor cells are susceptible to Zika virus infection
E.I. Rubio-Hernández, Mauricio Comas-García, Miguel Angel Coronado-Ipiña, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283429-e0283429
Open Access | Times Cited: 17
The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions
M Verhaegen, Kurt Vermeire
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Luis Adrián De Jesús‐González, Rosa M. del Ángel, Selvin Noé Palacios-Rápalo, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 6
Structural Biology of Flavivirus NS1 Protein and Its Antibody Complexes
Bing Liang Alvin Chew, Qi Pan, Hongli Hu, et al.
Antiviral Research (2024) Vol. 227, pp. 105915-105915
Open Access | Times Cited: 5
The dengue virus NS1 protein; new roles in pathogenesis due to similarities with and affinity for the high-density lipoprotein (HDL)?
Ana C. Alcalá, Juan E. Ludert
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011587-e1011587
Open Access | Times Cited: 12
Virus-host protein-protein interactions as molecular drug targets for arboviral infections
Mandar Bhutkar, Vishakha Singh, Preeti Dhaka, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 17
An ivermectin – atorvastatin combination impairs nuclear transport inhibiting dengue infection in vitro and in vivo
Selvin Noé Palacios-Rápalo, Carlos Noe Farfan‐Morales, Carlos Daniel Cordero‐Rivera, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108294-108294
Open Access | Times Cited: 11
Investigating how dengue virus-induced metabolic changes affect the host immune response and how to develop Immunomodulatory strategies
Fatemeh Amini Chermahini, Pooria Mohammadi Arvejeh, Francesco M. Marincola, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Metformin as a potential treatment for COVID-19
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 10, pp. 1199-1203
Closed Access | Times Cited: 8
Metabolic Enzymes in Viral Infection and Host Innate Immunity
Chao Qin, Taolin Xie, Wayne W. Yeh, et al.
Viruses (2023) Vol. 16, Iss. 1, pp. 35-35
Open Access | Times Cited: 6
Viperin mutation is linked to immunity, immune cell dynamics, and metabolic alteration during VHSV infection in zebrafish
K.A.S.N. Shanaka, Sumi Jung, K.P. Madushani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
Andréa Cottignies-Calamarte, Flora Marteau, Feifan He, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Influenza Virus-Based Antiviral Strategy: A Broad-Spectrum Potential of a Marine Bacterium Targeting Future Pandemics
Kyeong-Seo Moon, Grace Choi, Subin Jung, et al.
(2024)
Open Access | Times Cited: 1
Effects of the oxoaporphine alkaloid hernandonine on dengue virus. Evidence for its mechanisms of action
Ying‐Chieh Liao, Chih-Ching Yeh, Yu-Fan Chueh, et al.
Phytomedicine (2024) Vol. 134, pp. 155986-155986
Closed Access | Times Cited: 1
Drug Repositioning as an Antiviral Strategy Against Emerging Viruses
Selvin Noé Palacios-Rápalo, Carlos Daniel Cordero‐Rivera, Luis Adrián De Jesús‐González, et al.
˜The œLatin American studies book series (2024), pp. 273-317
Closed Access | Times Cited: 1
Oncogenic viruses and host lipid metabolism: a new perspective
Zhiyuan Gong, Zhiyong Yan, Wen Liu, et al.
Journal of General Virology (2023) Vol. 104, Iss. 6
Closed Access | Times Cited: 2
Sphingomyelins in mosquito saliva modify the host lipidome to enhance transmission of flaviviruses by promoting viral protein levels
Hacène Medkour, Lauryne Pruvost, Elliott F. Miot, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Machine learning-based gene expression biomarkers to distinguish Zika and Dengue virus infections: implications for diagnosis
Ayesha Zeba, Aruna Rajalingam, K. Sekar, et al.
VirusDisease (2024) Vol. 35, Iss. 3, pp. 446-461
Closed Access
Page 1 - Next Page

Scroll to top